Activated protein C resistance and the FV : R(506)Q mutation in a random population sample - Associations with cardiovascular risk factors and coagulation variables
Gdo. Lowe et al., Activated protein C resistance and the FV : R(506)Q mutation in a random population sample - Associations with cardiovascular risk factors and coagulation variables, THROMB HAEM, 81(6), 1999, pp. 918-924
Activated protein C (APC) resistance, defined as a low APC ratio, is associ
ated with the factor V mutation R(506)Q (factor V Leiden). APC ratio map al
so be influenced by other clinical and coagulation variables, which we stud
ied in 460 men and 495 women aged 25-74 years, from a random population sam
ple (Glasgow MONICA Survey). APC ratio correlated positively with APTT; and
inversely with factor VIIIc, factor IXc, antithrombin activity, prothrombi
n F1+2 fragment, and thrombin-antithrombin complexes; but not with other co
agulation variables. APC ratio decreased with age, but APTT did not. APC ra
tio and APTT were significantly lower in women versus men? and were signifi
cantly lower in users of oral contraceptives or hormone replacement therapy
. The EV:R(506)Q mutation (prevalence 2.5%) was associated with lower APC r
atio and protein C and S activities and with higher factor VIIIc levels; bu
t not with increases in F1+2 fragment or thrombin-antithrombin complexes. A
PC ratio correlated inversely with total cholesterol and di astolic blood p
ressure; and in women with triglycerides, systolic blood pressure, and body
mass index. Obesity was associated with a significantly lower APC ratio. I
n contrast, smoking markers correlated positively with APC ratio in men. Th
ese associations of APC ratio may be relevant to the increased risks of ven
ous thrombosis with age, female sex, oestrogen use,obesity and high factor
VIIIc levels. The association of APC resistance with elevated plasma levels
of coagulation markers suggests that this phenotype represents an in vivo
hypercoagulable state.